- Home
- CNTA vs BIRK Comparison
CNTA vs BIRK Comparison
Compare CNTA & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | BIRK |
|---|---|---|
| Founded | 2020 | 1774 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.0B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CNTA | BIRK |
|---|---|---|
| Price | $39.62 | $32.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | $43.17 | ★ $61.43 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | N/A | $14.30 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $31.33 |
| 52 Week High | $40.26 | $57.39 |
Technical Indicators
Market Signals| Indicator | CNTA | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 35.27 |
| Support Level | $39.36 | N/A |
| Resistance Level | $39.86 | $42.11 |
| Average True Range (ATR) | 0.14 | 1.90 |
| MACD | -0.33 | -0.86 |
| Stochastic Oscillator | 50.50 | 9.21 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.